Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells
Article in Cancer Immunology, Immunotherapy (January 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Cancer Immunology, Immunotherapy (January 2024)
Article in Frontiers in Oncology (October 2023)
Article in Current Treatment Options in Oncology (October 2023)